AACHEN, Germany and TORONTO, Feb. 24, 2025 /PRNewswire/ — Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. (“Apotex”), the largest Canadian-based pharmaceutical company, announced today that they have entered into a strategic licensing agreement…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.